US FDA is moving forward with an ambitious reorganization plan that will see device center staff grouped more closely by the products they work on, rather than by the stage in the review process.
The reorganization, officially announced on March 13 but in the works since mid-2017, is set to begin March 19 and will phase in the changes gradually over the next several months. FDA is aiming for the reorg to be complete by Sept. 30
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?